CAPOS syndrome

CAPOS syndrome is a very rare, inherited neurological condition first described in 1996 and traced to a single spelling mistake (missense variant Glu818Lys and a few close cousins) in the ATP1A3 gene. That gene builds the α‑3 sub‑unit of the sodium‑potassium pump—an enzyme that lets nerve cells fire in a coordinated way. When the pump is misshapen, nerve cells mis‑fire, which shows up as sudden unsteady walking (ataxia) during a childhood fever and gradually settles into a lifelong pattern of poor balance, weak reflexes, high‑arched feet, fading eyesight, and progressive deafness.PMCMedlinePlus

Because CAPOS sits on the same genetic continuum as alternating hemiplegia of childhood (AHC) and rapid‑onset dystonia‑parkinsonism (RDP), doctors sometimes call it an “ATP1A3‑related disorder.”PMC So far, fewer than 300 patients are reported worldwide

CAPOS is an acronym that spells out the five core problems usually seen together:

• Cerebellar Ataxia – trouble with balance and coordination

• Areflexia – reduced or absent reflexes

• Pes Cavus – a very high foot arch

• Optic Atrophy – thinning of the optic nerve that carries visual signals

• Sensorineural hearing loss – inner‑ear/nerve‑based deafness

Doctors today classify CAPOS as one of the “ATP1A3‑related neurological disorders.” A single spelling mistake (most often the p.Glu818Lys change) in the ATP1A3 gene on chromosome 19 stops the α‑3 sub‑unit of the sodium‑potassium pump from working properly. Because this pump resets electrical activity in neurons, the mutation makes brain, optic‑nerve, inner‑ear and muscle‑spindle cells abnormally sensitive to heat or fever. EyeWiki

The first attack usually strikes between six months and five years of age. A child develops a high fever from a cold or vaccination, then suddenly loses balance, speech and vision for days or weeks. Over months most skills return, but some damage—especially optic‑nerve thinning, hearing loss and weak reflexes—tends to stay for life. Later spikes of body temperature, childbirth, or other major stress can trigger one to three similar relapses. Rare Diseases Information CenterBioMed Central

CAPOS is rare—fewer than 1 000 people are thought to be living with it worldwide, with no clear sex or ethnic preference. Most cases are “de novo” (a brand‑new error in the child), but about one‑third are inherited in an autosomal‑dominant pattern: a parent who carries the faulty gene has a 50 % chance of passing it on to each child. Rare Diseases Information Center

---

Types

Because only a few dozen families have been described, doctors do not agree on formal sub‑types. For daily practice, dividing the condition by its timing and trigger helps to predict outlook and counseling.

1. Classic febrile‑onset CAPOS
   The scenario first reported in 1996. A single spell of high fever in infancy unleashes an acute ataxic encephalopathy. Permanent optic‑nerve and cochlear damage emerge over the next few years, while balance and speech partly recover.

2. Recurrent‑episode CAPOS
   The same genetic error, but the nervous system stays “irritable.” Children (and sometimes pregnant adults) experience two or more full relapses whenever temperature rises above ~38 °C. Each episode leaves an incremental hit on hearing, sight and gait.

3. CAPOS‑plus / mixed ATP1A3 phenotype
   Overlap with sister disorders. Some families have the E818K or other ATP1A3 variants that blur the line between CAPOS, rapid‑onset dystonia‑parkinsonism and alternating hemiplegia of childhood. Movement‑disorder specialists label these cases CAPOS‑plus because they show extra features such as dystonia, parkinsonian rigidity or epileptic seizures.

---

Evidence‑based “causes” or triggers

1. Pathogenic ATP1A3 mutation – the root molecular cause; without it CAPOS does not occur. EyeWiki

2. De‑novo gene change during embryo development – explains isolated cases born to healthy parents.

3. Autosomal‑dominant inheritance from an affected parent – 50 % transmission risk. Rare Diseases Information Center

4. Fever from viral infection – the commonest trigger for the first or later attacks; heat worsens pump leakiness. BioMed Central

5. Post‑vaccination temperature spikes – any immunization that gives a short fever can set off an episode.

6. Prolonged hyperthermia from environmental heat – heat‑wave exposure reported as a catalyst in some teenagers.

7. Severe systemic inflammation (cytokine storm) – interleukins further hamper ion‑pump function.

8. Rapid hormonal shifts in pregnancy and delivery – estrogen and oxidative stress can unmask latent pump weakness. Rare Diseases Information Center

9. Metabolic stress of growth spurts – higher neuronal firing rates make the ionic flaw more obvious.

10. Seizures raising brain temperature – self‑reinforcing circle: fever → seizure → higher core heat.

11. Strenuous exercise without cooling – anecdotal reports of cerebellar wobble after sports matches in hot climates.

12. Concurrent mitochondrial dysfunction – animal data show that defective Na⁺/K⁺ pumps overload mitochondria.

13. Modifier polymorphisms in ATP1A2 or ion‑channel genes – may explain why severity differs among siblings.

14. Chronic otitis media with high‑grade fever – middle‑ear infections often precede sensorineural decline.

15. Autoimmune encephalitis overlap – rare cases where antibodies plus ATP1A3 mutation compound neuronal stress.

---

Symptoms

1. Sudden cerebellar ataxia – the child cannot sit, stand or walk straight; slurred speech and hand tremor appear as the cerebellum misfires.

2. Areflexia – knee‑jerk and ankle reflexes fade because nerve‑muscle communication stalls, even though nerves are structurally intact.

3. Pes cavus – tight, high‑arched feet develop slowly after repeated neurological injury, much like in hereditary neuropathies.

4. Optic atrophy – the optic nerves pale on eye exam; central vision blurs first, later peripheral sight and color discrimination suffer.

5. Sensorineural hearing loss – high tones or low tones (depending on cochlear segment) disappear; many children need hearing aids or cochlear implants by school age. PubMed

6. Nystagmus or strabismus – jerky or misaligned eye movements reflect cerebellar and vestibular imbalance.

7. Dysarthria – words sound slushy because cerebellar control of tongue and palate is off‑timed.

8. Dysphagia – swallowing feels slow or “sticks,” raising the risk of gagging or aspiration.

9. Limb or generalized weakness – sodium‑potassium disequilibrium makes muscle fibers less excitable during attacks.

10. Chronic fatigue and cognitive fog – subtle energy drain from repeated neuronal stress leaves many teens with poor concentration.

---

Diagnostic tests

Physical‑examination based 

1. Full neurological exam – bedside assessment of gait, coordination, reflexes and cranial nerves provides the first diagnostic clues.

2. Gait analysis and Romberg test – watching the patient walk heel‑to‑toe and stand with eyes closed highlights truncal sway typical of cerebellar disease.

3. Ophthalmoscopy – direct view of pale optic discs confirms optic‑nerve damage in vivo.

4. Otoscopy and tuning‑fork checks – simple office tools detect early sensorineural loss versus middle‑ear problems.

Manual/bedside maneuver tests

1. Heel‑to‑shin and finger‑nose tests – classic cerebellar tasks expose past or present incoordination even when the patient looks steady.
2. Deep tendon reflex tap – absent knee‑jerk supports the “A” (areflexia) in CAPOS.
3. Whisper or Rinne/Weber test – validates audiometric findings without machines.

Laboratory & pathological investigations

1. Next‑generation sequencing of ATP1A3 – the gold‑standard confirmatory test; finds the p.Glu818Lys or other missense errors. EyeWiki
2. Targeted familial mutation testing – rapid PCR screen for relatives once the proband’s variant is known.
3. 10. Basic metabolic panel and electrolytes – rules out acquired ataxias caused by sodium, potassium, calcium or glucose imbalance.
4. Inflammatory markers (CRP, ESR) and viral serology – pinpoints fever source and separates infectious encephalitis from genetic relapse.
5. Urine organic‑acid profile – excludes metabolic crises (e.g., pyruvate dehydrogenase deficiency) that can mimic CAPOS.

Electrodiagnostic studies 

1. Auditory brain‑stem response (ABR) – shows absent or poorly formed waveforms despite normal otoacoustic emissions, proving neural hearing loss. PubMed
2. Electroretinogram (ERG) & visual evoked potentials – gauge retinal versus post‑retinal visual pathway health.
3. Nerve‑conduction studies – typically normal; their normality helps distinguish CAPOS from peripheral neuropathies with pes cavus.
4. Electroencephalogram (EEG) – documents encephalopathy or seizure activity during acute episodes.

Imaging tests 

1. Brain MRI with cerebellar protocol – often surprisingly normal, but can show subtle cerebellar cortical thinning or optic‑nerve signal change. BioMed Central
2. Optical coherence tomography (OCT) – high‑resolution scan that quantifies retinal‑nerve‑fiber‑layer thinning long before vision drops.
3. High‑resolution CT or MRI of the inner ear and temporal bone – rules out structural cochlear malformations.
4. Weight‑bearing foot X‑ray or CT – documents pes cavus angle and guides orthopedic planning if braces or surgery are considered.

Non‑pharmacological therapies

A. Exercise & physical therapies

1. Intensive balance training – task‑specific stepping, obstacle courses, dynamic postures; rewires cerebellar plasticity and halves fall risk in hereditary ataxia.PubMed

2. Core‑stability home programme – planks, bridges, Theraband work; bolsters trunk control, easing ataxic sway.PubMed

3. Treadmill gait training with partial body‑weight support – provokes rhythmic stepping and improves gait speed and endurance.PubMed

4. Aquatic therapy – buoyancy cuts joint load so patients can practise larger ranges.

5. Vestibular rehabilitation – gaze‑stabilisation and head‑movement drills reduce oscillopsia.

6. Trans‑cranial direct‑current stimulation (ctDCS) paired with posture work – low‑level cerebellar current modulates Purkinje excitability, giving short‑term ataxia relief.PubMed

7. Orthotic foot bracing – custom carbon‑fiber AFOs curb ankle sprains and improve push‑off.

8. Constraint‑induced hand therapy – forces use of ataxic limb, enhancing coordination.

B. Mind‑body approaches

9. Mindfulness‑based stress reduction (MBSR) – lowers sympathetic spikes that exacerbate tremor.

10. Yoga for neurological balance – slow flows improve proprioception and core stability simultaneously.

11. Guided imagery & breathing drills – dampen hyper‑ventilatory dizziness.

12. Cognitive‑behavioural therapy (CBT) – equips families to manage chronic disability and hearing decline.

13. Music‑supported therapy – rhythmic entrainment improves timing and speech prosody.

14. Biofeedback gait lab sessions – visual feedback of centre‑of‑pressure teaches safer foot placement.

C. Educational & self‑management tools

15. Fever action plan – parents learn to start antipyretics and extra fluids at 37.5 °C to avert attacks.

16. Low‑vision training & magnifiers – teaches eccentric viewing and optimal lighting for optic atrophy.NCBI

17. Auditory rehabilitation & lip‑reading classes – boost communication after cochlear or hearing‑aid fitting.PMC

18. Assistive‑tech orientation – smartphone speech‑to‑text, FM classroom systems, tactile cueing apps.

19. Genetic counselling – clarifies 50 % autosomal‑dominant inheritance risk for future pregnancies.

20. Peer‑support groups & telehealth follow‑up – lower isolation, reinforce therapy goals.

---

Key medicines used in practice (benefits & cautions)

*Always individualise; paediatric neurologist input essential.

---

Dietary molecular supplements

1. Coenzyme Q10 (5–15 mg/kg/day) – restores mitochondrial electron shuttling and acts as an antioxidant; small studies improve hereditary ataxia stamina.PMCmitoaction.org

2. Alpha‑lipoic acid (600 mg/day) – quenches free radicals and down‑regulates pain receptors; evidence robust for neuropathy symptom relief.PMCPMC

3. Omega‑3 EPA/DHA (1–2 g/day) – anti‑inflammatory, supports neuronal membrane fluidity.

4. Acetyl‑l‑carnitine (1 g BID) – ferry fatty acids into mitochondria, improves nerve conduction velocity.

5. Vitamin E (400 IU/day) – scavenges lipid peroxides protecting retinal ganglion cells.

6. Vitamin B‑complex (B1 100 mg + B6 50 mg + B12 1 mg/day) – co‑factors for nerve myelination.

7. Magnesium citrate (200–400 mg nightly) – supports energy production and eases muscle cramps.

8. Curcumin (500 mg BID with pepper) – NF‑κB inhibition lowers neuro‑inflammation.

9. Lutein & zeaxanthin (10/2 mg daily) – concentrate in retina and may slow optic‑nerve oxidative stress.

10. N‑acetyl‑cysteine (600 mg BID) – boosts glutathione, the cell’s master antioxidant.

Supplements are adjuncts, not cures; discuss interactions with the care team.Verywell Health

---

Regenerative or stem‑cell‑powered therapies on the horizon

1. AAV‑mediated inner‑ear gene therapy – in mouse models, viral delivery of healthy genes restores hair‑cell function and partial hearing; human first‑in‑human trials for single‑gene deafness began in 2024.PubMed

2. iPSC‑derived cochlear hair‑cell transplantation – lab‑grown progenitors placed into damaged cochleae are maturing into mechanosensory cells in early animal studies.PubMed

3. Retinal ganglion‑cell replacement – stem‑cell–derived RGCs injected into the vitreous integrate with optic nerve head in primate experiments, offering hope for optic‑atrophy blindness.PMCAAO

4. Optic‑nerve gene modulation (SARM1 inhibitors) – blocking the programmed‑axon‑death pathway spares retinal axons after stress, a strategy entering phase I safety studies.Nature

5. Neural‑stem‑cell exosome therapy – nano‑vesicles packed with growth factors reduce inflammation and promote synaptic repair in early rodent ataxia models.

6. CRISPR prime‑editing for ATP1A3 – precision gene correction achieved in human cortical organoids; ethical and delivery hurdles remain but proof‑of‑concept is in place.PubMed

These interventions are experimental, offered only in regulated trials.

---

Surgical options and why they help

1. Cochlear implantation – places an electrode array inside the cochlea, bypassing damaged hair cells to deliver sound directly to the auditory nerve; improves speech perception and quality‑of‑life even in single‑sided deafness.NCBIPubMed

2. Percutaneous cavus‑foot correction – minimally invasive osteotomies realign the arch, relieve plantar‑lateral overload and cut sprain frequency.PMC

3. Japas V‑osteotomy (open cavus correction) – wedges mid‑foot bones to flatten the arch while preserving subtalar motion; durable in rigid deformities.PMC

4. Strabismus muscle surgery – realigns eyes when nystagmus leads to squint, reducing double vision strain.

5. Cataract extraction with low‑vision rehab integration – if lens opacity co‑exists, removal maximises residual vision for optic‑atrophy patients.American Optometric Association

---

Smart prevention habits

1. Keep digital thermometers handy and treat any child’s fever early.

2. Ensure up‑to‑date vaccinations to avoid serious infections.

3. Practise rigorous hand‑washing during flu seasons.

4. Use cooling vests or shaded breaks during high‑heat activities.

5. Prioritise 8–10 hours of night‑time sleep to minimise metabolic stress.

6. Schedule regular hearing and vision checks for early device fitting.

7. Fit orthotic insoles early to slow foot deformity.

8. Teach children to hydrate well during sport or illness.

9. Avoid binge drinking and stimulant beverages in teens/adults.

10. Seek genetic counselling before family planning.

---

When should you see a doctor?

Call your paediatric neurologist or emergency services immediately if a child with CAPOS develops a temperature ⩾ 38 °C, sudden stumbling, slurred speech, new eye shaking, rapid hearing drop, unexplained severe foot pain, or seizure‑like shaking. For adults, any rapid vision fade, sudden vertigo, or new weakness also warrants urgent review.

---

What to do & what to avoid (quick tips)

Do

1. Keep fever‑reducers (paracetamol/acetaminophen) in the home kit.

2. Encourage daily balance drills—5 minutes counts.

3. Use sunglasses and hats; optic‑atrophy eyes are light‑sensitive.

4. Label hearing‑aid batteries and store spares in travel packs.

5. Attend physiotherapy reviews every 6–12 months.

Avoid
6. Skipping sleepovers without proper medication plans.
7. Extreme ketogenic diets without dietitian supervision.
8. Barefoot walking on uneven ground; risk ankle sprain.
9. Smoking & second‑hand smoke—compromises already‑stressed optic nerves.
10. Over‑the‑counter decongestants containing pseudoephedrine; may raise heart rate and trigger episodes.

---

Frequently asked questions

1. Is CAPOS always inherited? – Usually yes (autosomal‑dominant), but one‑third are new spontaneous mutations.

2. Can it skip generations? – Only if the carrier is mildly affected or undiagnosed.

3. Does the condition shorten life span? – Most people live a normal lifespan with supportive care.

4. Will my child lose all vision? – Optic atrophy is slowly progressive; low‑vision aids preserve functional sight for many years.

5. Are attacks painful? – The ataxic spells feel more frightening than painful; foot pain stems from deformation.

6. Can physiotherapy reverse the foot arch? – It can slow progression but surgery is needed for rigid deformity.

7. Do hearing aids work? – Yes, but auditory neuropathy may require cochlear implants for clear speech understanding.

8. Is acetazolamide safe long‑term? – Decades of episodic‑ataxia data show it is generally safe with kidney monitoring.

9. What about ketogenic diet? – Small studies in ATP1A3 disorders suggest it can reduce episodes but it is hard to maintain and needs specialist oversight.PMC

10. Can stem cells cure the disease now? – Not yet; human trials are just beginning.

11. Does stress really trigger attacks? – Yes, through cortisol and body‑temperature spikes.

12. Can CAPOS mimic multiple sclerosis? – White‑matter MRI is usually normal, helping differentiate.

13. Is pregnancy risky for mothers with CAPOS? – Most carry safely but need pre‑delivery neurologic and anaesthetic planning.

14. Are there disease‑modifying drugs in trials? – Researchers are exploring sodium‑pump stabilisers and gene editing.

15. Where can families find support? – Start with Orphanet, local rare‑disease alliances, and CAPOS social‑media groups.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 15, 2025.